Campylobacter jejuni, the most common cause of food-borne infectious illnesses in the United States (1), encodes a toxin termed CDT, which is considered to be an important virulence factor (2) (3) (4) . This toxin causes eukaryotic cells to arrest in the G 2 /M transition phase of the cell cycle (5) . Intoxicated cells show a characteristic accumulation of the phosphorylated form of the cell cycle regulator CDC2, as well as an increase in their DNA content (4N), consistent with a cell cycle blockage at the G 2 /M boundary (6 -10) . After intoxication, cell division stops, but the cytoplasm continues to grow and distend, resulting in cells up to five times their normal size. Intoxicated cells maintain viability for extended periods of time, although they eventually show morphological changes in the chromatin such as condensation and/or fragmentation and ultimately die. In addition to C. jejuni, CDT-homologous toxins have been described in several other important bacterial pathogens (11) (12) (13) (14) (15) (16) (17) , but little is known about their mechanism of action. CDTs are encoded by a cluster of three highly conserved genes of unknown function, cdtA, cdtB, and cdtC (4) .
To investigate which of the Cdt subunits may have toxic activity within the host cell, we transfected COS-1 cells with plasmids expressing epitope-tagged CdtA, CdtB, or CdtC or vector control (18) . Cells expressing CdtA or CdtC or transfected with the vector control displayed an apparently normal morphology and showed no signs of intoxication ( Fig. 1) . In contrast, cells transfected with a plasmid expressing CdtB exhibited striking alterations characterized by fragmented nuclei and often a total collapse of the chromatin (Fig. 1) . Changes in the chromatin were apparent as early as 18 to 24 hours after transfection when nuclei of transfected cells began to exhibit a distinct smooth appearance (Fig. 1) . Forty-eight hours after transfection, the nuclei of transfected cells appeared seriously compromised, exhibiting marked fragmentation or outright disappearance of the chromatin (Fig. 1) . Thus, CdtB was responsible, at least in part, for the activity of the CDT toxin within the host cell.
We examined the predicted amino acid sequence of this toxin subunit in an effort to identify clues about its function. Amino acid sequence comparison revealed similarity to deoxyribonuclease (DNase) I-like proteins. Further alignment of CdtB with members of the DNase I protein family revealed a striking conservation of most residues that mutagenesis and structural analysis have shown to be essential for enzymatic activity (19 -21) ( Fig.  2A) . These include residues that are part of the active site as well as residues that are important for Mg 2ϩ binding, an essential requirement for the catalytic activity of this family of proteins (21). Further sequence comparison revealed that these residues are absolutely conserved in all CdtB proteins from other bacterial pathogens.
To confirm the putative DNase activity of CdtB, we constructed mutant derivatives of this toxin subunit carrying single amino acid substitutions in residues that have been shown to be critical for the catalytic activity of members of the type I DNase family of proteins (22 D185S were transfected into COS-1 cells, and 48 hours after transfection, the cells were stained with an antibody directed to the epitope tag and with 4Ј,6Ј-diamidino-2-phenylindole (DAPI) to examine the structure of the chromatin. Cells transfected with either of these plasmids exhibited completely normal nuclear morphology despite the presence of high levels of mutant CdtB protein as judged by the bright fluorescence staining and Western blot analysis (Fig. 2B ). This was in sharp contrast to cells transfected with wild-type CdtB, which showed a complete collapse of their chromatin (Fig. 2B) . The mutant CdtB proteins exhibited exclusive nuclear localization, implicating the nucleus as the site of action for this toxin subunit and consistent with its potential role as a DNase (Fig. 2B ). Because CdtB does not exhibit a detectable consensus nuclear localization signal (NLS), its mechanism of translocation to the nucleus may involve either an atypical NLS or a carrier protein (23).
To confirm the toxic activity of CdtB, we purified this protein to homogeneity and microinjected it into cells (24) (Fig. 3B ). Microinjection into COS-1 or REF52 cells of a 1 mg/ml solution of purified CdtB resulted in marked changes in the chromatin as early as 4 hours after microinjection (Fig. 3A) . In contrast, microinjection of equal amounts of CdtB H152Q purified in identical fashion did not cause any visible alteration to the chromatin of microinjected cells (Fig. 3A) . Both wild-type CdtB and CdtB H152Q were exclusively localized to the nucleus (Fig. 3A) .
The morphological changes induced by the overexpression of CdtB or the microinjection of a 1 mg/ml solution of purified CdtB do not completely resemble those changes induced by CDT holotoxin intoxication. We hypothesized that this difference could be the result of the vastly different intracellular levels of CdtB under these two different conditions. To test this hypothesis, we microinjected into COS-1 and REF52 cells increasingly lower amounts of purified CdtB protein and examined the effects on cellular and nuclear morphology (25). Microinjection of a solution containing purified CdtB (1 g/ml) resulted in vast distention of the cell cytoplasm and severe enlargement of the nucleus 4 to 5 days after microinjection (Fig. 3B) . These changes closely resemble those induced by the CDT holotoxin, indicating that, when microinjected into cells, CdtB by itself was capable of recapitulating the toxic effects observed by CDT holotoxin treatment. As expected, microinjection of similar amounts of CdtB H152Q did not result in any detectable cellular changes (25).
To investigate the importance of the DNase activity of CdtB on the toxicity of the CDT holotoxin, we constructed plasmids that encode the mutant proteins CdtB H152Q or CdtB D185S along with CdtA and CdtC in the same genetic organization as that of the wildtype locus (26). Extracts from Escherichia coli strains carrying these plasmids or the wild-type cdtABC locus were prepared, and their toxicity was examined by a variety of assays (27). The levels of the CdtB mutant proteins as well as those of the other components of the holotoxin were equivalent in all the extracts used in these studies (Fig. 4C) .
Extracts from E. coli expressing wild-type CdtB induced marked morphological changes in intoxicated cells characterized by a marked distention and enlargement of the cell cytoplasm and nucleus (Fig. 4A) . In contrast, cells treated with extracts from E. coli expressing the catalytic (CdtB H152Q ) or the Mg 2ϩ -binding (CdtB D185S ) mutants exhibited the same morphology as cells treated with extracts from E. coli carrying the vector alone (Fig. 4A) . To examine the effect of the mutant toxins on cell cycle progression, we analyzed by flow cytometry the DNA content of cells treated with the same extracts of E. coli expressing wild-type or mutant forms of CdtB. Consistent with a G 2 /M block, cells intoxicated with extracts from bacteria expressing wild-type holotoxin exhibited a 4N DNA content (Fig. 4B) . In contrast, the flow cytometric profiles of cells infected with extracts from bacteria expressing either of the mutant forms of CdtB (CdtB H152Q or CdtB D185S ) were indistinguishable from the profile of untreated cells or cells treated with extracts from bacteria carrying the empty vector (Fig. 4B) . Thus, CdtB DNase activity is essential for CDT toxicity.
DNA damage triggers a series of carefully controlled processes that stop cell cycle progression to ensure that cell division will not proceed to the next phase until the DNA damage has been repaired (28). The G 2 /M cell cycle arrest induced by CDT toxins is therefore most likely the consequence of DNA damage inflicted by the DNase activity . As a control, cells were treated with an extract of E. coli carrying the empty vector (vector). Images were captured 48 hours after treatment with a Nikon Diaphot inverted microscope fitted with a Princeton Instruments Micromax digital camera. Scale bar, 50 m. (B) Cell cycle progression of Henle-407 intestinal epithelial cells after treatment with CDT toxin containing different CdtB mutants. Henle-407 cells were treated in an identical manner and with the same preparations described in (A). Seventytwo hours after treatment, cells were fixed, stained, and examined for DNA content by flow cytometry (27). The peaks corresponding to cells in G 0 -G 1 , S, or G 2 are indicated. A minimum of 10,000 nuclei per sample were analyzed. (C) Expression of CdtA, CdtC, and wild-type CdtB or its mutant derivatives CdtB H152Q or CdtB D185S in the extracts used in experiments described in (A) and (B). Whole-cell lysates (labeled A) and sonicated extracts (labeled B) were separated by SDS-polyacrylamide gel electrophoresis, and the levels of the CdtA, CdtB, and CdtC proteins were evaluated by Western immunoblot with specific antibodies.
of its CdtB subunit upon delivery into the cell. Although DNA damage can lead to cell cycle arrest in either G 1 /S or G 2 /M, CDTintoxicated cells invariably arrest in G 2 /M. A plausible explanation for this observation may be that CdtB DNase activity is directed to single-stranded DNA only present during the S phase of the cell cycle, which immediately precedes G 2 . Alternatively, CdtB may have access to the chromatin only in G 2 or may require a cofactor for its activity that is only available in this phase of the cell cycle. Consistent with either hypothesis, purified CdtB exhibited only very poor DNase activity in vitro, which was only detectable on single-stranded DNA templates.
Bacterial infections are increasingly considered a potential predisposing factor for the development of cancer. The presence of a bacterial toxin capable of causing DNA damage in a commonly occurring intestinal pathogen such as C. jejuni may not only aid its pathogenicity but may constitute a predisposing factor for intestinal cancer.
then cloned into the mammalian expression vector pSG5 (Stratagene) and expressed in COS-1 cells. All constructions were verified by nucleotide sequencing. The M45 epitope-tagged versions of the three Cdt proteins were shown to function in a manner indistinguishable from that of wild type. Transfections were carried out with 0.2 g of plasmid DNA with the FuGENE6 (Roche) reagent following the recommendations of the manufacturer. Twenty-four or 48 hours after transfection, cells were fixed and stained with monoclonal antibody to M45 and DAPI as previously described (30 were microinjected into the cytoplasm of COS-1 and REF52 cells, and the morphological changes were followed over time by standard microscopy. These preliminary experiments involved the microinjection of at least 50 cells for each protein dilution. Once the CdtB dilutions that led to cytoplasmic distention were identified, a more detailed examination of microinjected cells was carried out involving the staining of the nucleus with DAPI and subsequent examination under a fluorescence microscope. Microinjected cells were identified by comicroinjection of FITC-labeled dextran. In this case, a minimum of 300 cells in different experiments were examined. When a concentration of 1 g/ml was used, 4 days after microinjection, ϳ50% of the cells exhibited cytoplasmic distention, ϳ20% showed no changes, and ϳ30% showed compromised chromatin. The difference in response is most likely due to differences in the actual amount of protein microinjected into the cells, which may vary from cell to cell. 26. A wild-type operon encoding a COOH-terminal M45 epitope-tagged CdtB was constructed by amplifying a fragment containing cdtAB by polymerase chain reaction (PCR) and cloning it into the epitope-tagging vector pSB616 (29) . A DNA fragment containing cdtC and its ribosome-binding site was amplified by PCR and cloned into a site located immediately downstream of the epitope tag. The resulting plasmid, pSB1735, encodes an operon composed of cdtA cdtB-M45 cdtC. DNA fragments encoding either the epitope-tagged CdtB H152Q or CdtB D185S proteins were swapped with the wild-type copy of cdtB-M45 present in pSB1735 with unique restriction sites. All constructs were verified by nucleotide sequence analysis. 27. Henle-407 intestinal epithelial cells were treated with filter-sterilized cell extracts from sonicated cultures of E. coli strains expressing the wild-type cdtABC locus, the mutant derivatives cdtAB H152Q C or cdtAB D185S C, or extracts from E. coli carrying the empty vector. In all cases, expression of these genes was under the control of the strong para ABC promoter. For cell cycle analysis, Henle-407 intestinal epithelial cells were seeded on 60-mm tissue culture dishes and treated with the different filter-sterilized lysates of E. coli strains as indicated above with a dose sufficient to intoxicate 100% of the cells present on the dish. Forty-eight hours after intoxication, cells were processed for flow cytometry as follows. Cells were collected from dishes by trypsinization, and trypsin was neutralized with serum containing media. The cell suspensions were centrifuged for 5 min at 1500 rpm at room temperature, the supernatants were removed, and the cell pellets were resuspended in 0.5 ml of phosphatebuffered saline (PBS) at room temperature. The cell suspensions were slowly added to tubes containing 4 ml of cold (Ϫ20°C) 90% ethanol solution under continuous mixing. Cells were kept in fixative for at least 2 hours on ice. The fixed cells were collected by centrifugation, and the fixative was decanted thoroughly. The pellet was washed once with 5 ml of PBS, and the cell pellet was resuspended in 1 ml of a solution containing 0.1% Triton X-100, DNase-free ribonuclease A (20 mg/ml), and propidium iodide (20 g/ml; Molecular Probes) in PBS. The stained cells were analyzed by flow cytometry with a FACStar Plus flow cytometer (Beckton Dickinson).
